Senti Biosciences, Inc. financial data

Symbol
SNTI on Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
Location
2 Corporate Drive, First Floor, South San Francisco, CA
State of incorporation
DE
Fiscal year end
December 31
Former names
Dynamics Special Purpose Corp. (to 6/13/2022)
Latest financial report
10-Q - Q3 2024 - Nov 14, 2024

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 467 % -26.2%
Debt-to-equity 100 % +112%
Return On Equity -269 % -156%
Return On Assets -135 % -88%
Operating Margin -27.3K % -1781%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 4.59M shares -89.7%
Common Stock, Shares, Outstanding 4.59M shares -89.7%
Entity Public Float 30.2M USD
Common Stock, Value, Issued 1K USD -75%
Weighted Average Number of Shares Outstanding, Basic 4.58M shares +2.92%
Weighted Average Number of Shares Outstanding, Diluted 4.58M shares +2.92%

Income Statement

Label TTM Value / Value Unit Change %
Revenues 0 USD -100%
Revenue from Contract with Customer, Excluding Assessed Tax 0 USD -100%
Research and Development Expense 35.7M USD +28.4%
General and Administrative Expense 27.3M USD -26.2%
Operating Income (Loss) -63.6M USD +27.6%
Nonoperating Income (Expense) -7.3M USD -166%
Income Tax Expense (Benefit) 0 USD
Net Income (Loss) Attributable to Parent -123M USD -11.5%
Earnings Per Share, Basic -2.62 USD/shares +50.3%
Earnings Per Share, Diluted -2.62 USD/shares +50.3%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 10.5M USD -73.4%
Cash, Cash Equivalents, and Short-term Investments 35.9M USD -63.6%
Accounts Receivable, after Allowance for Credit Loss, Current 567K USD
Other Assets, Current 8K USD -98.4%
Assets, Current 17.4M USD -78%
Property, Plant and Equipment, Net 22.2M USD -15.9%
Operating Lease, Right-of-Use Asset 14.5M USD -15%
Other Assets, Noncurrent 88K USD -50.3%
Assets 57.7M USD -56.2%
Accounts Payable, Current 793K USD -60.2%
Employee-related Liabilities, Current 1.57M USD -39.5%
Accrued Liabilities, Current 3.97M USD +396732%
Contract with Customer, Liability, Current 0 USD -100%
Liabilities, Current 9.06M USD -10.4%
Contract with Customer, Liability, Noncurrent 0 USD -100%
Operating Lease, Liability, Noncurrent 30.1M USD -13%
Other Liabilities, Noncurrent 2.54M USD
Liabilities 41.7M USD -14.5%
Accumulated Other Comprehensive Income (Loss), Net of Tax 0 USD -100%
Retained Earnings (Accumulated Deficit) -297M USD -31.4%
Stockholders' Equity Attributable to Parent 16M USD -80.7%
Liabilities and Equity 57.7M USD -56.2%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities -11.7M USD +28.3%
Net Cash Provided by (Used in) Financing Activities 0 USD
Net Cash Provided by (Used in) Investing Activities -9.5M USD -28.7%
Common Stock, Shares Authorized 500M shares 0%
Common Stock, Shares, Issued 4.59M shares -89.7%
Common Stock, Par or Stated Value Per Share 0 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect -11.7M USD +54.7%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 14M USD -69.4%
Deferred Tax Assets, Valuation Allowance 61.3M USD +45.7%
Cash and Cash Equivalents, Period Increase (Decrease) -493K USD
Deferred Tax Assets, Gross 64.8M USD +41.1%
Operating Lease, Liability 34.6M USD -6.95%
Depreciation 984K USD +111%
Payments to Acquire Property, Plant, and Equipment 15K USD -99.8%
Comprehensive Income (Loss), Net of Tax, Attributable to Parent -70.9M USD -0.49%
Lessee, Operating Lease, Liability, to be Paid 47.2M USD -13.2%
Property, Plant and Equipment, Gross 30.8M USD -2.63%
Operating Lease, Liability, Current 4.49M USD +73.5%
Lessee, Operating Lease, Liability, to be Paid, Year Two 7.71M USD +3.13%
Lessee, Operating Lease, Liability, to be Paid, Year One 7.48M USD +3.09%
Operating Lease, Weighted Average Discount Rate, Percent 0.09 pure 0%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount 12.6M USD -20.8%
Lessee, Operating Lease, Liability, to be Paid, Year Three 5.77M USD -25.2%
Deferred Tax Assets, Operating Loss Carryforwards 33.6M USD +32.9%
Preferred Stock, Shares Issued 0 shares
Preferred Stock, Shares Authorized 10M shares 0%
Unrecognized Tax Benefits 2.08M USD +26.4%
Lessee, Operating Lease, Liability, to be Paid, Year Four 4.86M USD -15.8%
Additional Paid in Capital 313M USD +1.28%
Preferred Stock, Shares Outstanding 0 shares
Share-based Payment Arrangement, Expense 5.41M USD -50.9%
Preferred Stock, Par or Stated Value Per Share 0 USD/shares 0%